About Massive Bio
Massive Bio is a company based in New York (United States) founded in 2014. Massive Bio has raised $14.13 million across 4 funding rounds from investors including ImpactAssets, Revo Capital and Kenan Turnacioglu. Massive Bio operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
- Headquarter New York, United States
- SectorsHealthcare
- Website category Health · Health Conditions and Concerns
- Email••••••••
- Phone•••• ••••
- Website massivebio.com
- Social LinkedIn X Facebook
- Total Equity Funding$14.13M (USD)
in 4 rounds
- Latest Funding Round$9M (USD), Series B
Jun 2022
- InvestorsImpactAssets
& 4 more
Funding Insights of Massive Bio
Massive Bio has successfully raised a total of $14.13M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $9 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.13M
- Total Rounds 4
- Last Round Series B — $9M
- Investors Count 5
All 4 funding rounds of Massive Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $9M | Series B | – | Revo Capital, Kenan Turnacioglu | |
| Nov 2020 | $2.6M | Series A | – | Revo Capital | |
| May 2019 | $2.53M | Seed | – | – | – |
| Sep 2016 | – | Seed | – | – |
5 investors in total: 4 institutional and 1 angel.
Investors in Massive Bio
Massive Bio has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include ImpactAssets, Revo Capital and Kenan Turnacioglu.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are directed by Revo Capital toward Turkey-based startups. | – | revo.vc | Amstelveen, Netherlands | |
Private equity firm focused on growth equities | – | deginvest.de | Cologne, Germany | |
Tech focused corporate VC firm investing in early stage startups in Turkey | – | 500istanbul.co | Istanbul, Turkey | |
Impact investing funds are managed to support mission-driven enterprises. | 2010 | impactassets.org | Bethesda, United States | |
KT Kenan Turnacioglu | Angel investor and entrepreneur, co-founder of Gram Games, active in tech startups | – | unknown_bff3fdc0379b48daa | - |
Investor details for Massive Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Massive Bio
25 people are tracked at Massive Bio (9 in leadership, 3 in board & advisors, 13 in team).
| Name | Role | Group |
|---|---|---|
Ertuğrul T. | Director Of Software Development | Leadership |
Cagatay M. Culcuoglu | Co-founder, CTO & COO | Leadership |
Selin Kurnaz | Co-Founder & CEO | Leadership |
Arturo Loaiza-Bonilla | Co-Founder & CMO | Leadership |
Jason Freedman | Chief Pediatric Advisor | Leadership |
Toygun Onaran | Chief Financial Officer | Leadership |
Ann Stevens | Director of Clinical Operations | Leadership |
David Henka | Senior Vice President Global Strategic Partnerships | Leadership |
Aycan Emre | Chief of Staff | Leadership |
Edgardo Santos | Advisor | Board & advisors |
Stefan Glück | Advisor | Board & advisors |
Maurie Markman | Advisor | Board & advisors |
Ertaç Güngör | Software Development Manager | Team |
Gokhan Gocmen | Software Team Lead | Team |
Ana Guillén | Patient Advocate | Team |
Sinan Gül | Junior Software Developer | Team |
Abdurrahman Taşkıran | Sr. HR & Operations Specialist | Team |
Josh Komins | Senior Marketing Analyst | Team |
Nikolai Derek | Marketing Specialist | Team |
Timothy Gower | Oncology Content Writer | Team |
5 more people are available in the full profile.
Complete people profiles for Massive Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Massive Bio
3 dated milestones of Massive Bio across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Massive Bio is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $9.0M.
Competitors of Massive Bio
Massive Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medidata.com | 1999 | New York, United States | $41.5M | 1,677 | Medidata is recognized as a leading provider of SaaS solutions for clinical research. | |
| verily.com | 2015 | Dallas, United States | $2.5B | – | AI-based solutions for health management are provided. | |
| trinetx.com | 2013 | Cambridge, United States | $53M | 95 | Clinical trial management software is provided for researchers and professionals. | |
| signanthealth.com | 2000 | Plymouth Meeting, United States | $3.4M | – | Signant Health is engaged in providing clinical trial technology solutions. | |
| wcgclinical.com | 2012 | Princeton, United States | – | 229 | Regulatory and ethical review services for clinical research are provided. | |
| ixico.com | 2004 | London, United Kingdom | – | 93 | AI-based medical image management and analysis solutions for healthcare organizations | |
| deep6.ai | 2013 | Pasadena, United States | $54.79M | 41 | AI enabled solutions for clinical trials | |
| clinicalink.com | 2006 | Winston-salem, United States | $13.15M | 283 | Paperless eSource and patient engagement solutions for clinical trials |
Detailed competitors of Massive Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Massive Bio
The website of Massive Bio (massivebio.com) receives about 155K visits a month and ranks #353,083 among all websites worldwide, #12,528 in Health Conditions and Concerns.
- Monthly visits155K
▲ 22.8% vs previous month
- Unique visitors63.1K
per month
- Global rank#353,083
among all websites
- Category rank#12,528
Health · Health Conditions and Concerns
- Bounce rate55%
- Pages per visit1.6
- Average visit49 sec
- DevicesDesktop 20% · Mobile 80%
Websites whose visitors overlap most with Massive Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mybcteam.com | 100% | – | #395,150 | View details | |
bcan.org | bcan.org | 92% | – | #643,885 | – |
| moffitt.org | 90% | 785.6K | #70,150 | View details | |
humanitas.net | humanitas.net | 87% | – | #635,243 | – |
melanomafocus.org | melanomafocus.org | 86% | – | #1,080,323 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Massive Bio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Massive Bio
Complete news archive for Massive Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Massive Bio
10 companies that operate in the same segment as Massive Bio (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Massive Bio
Massive Bio was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Massive Bio is headquartered in New York, United States. It is registered at New York, New York, United States.
Massive Bio is a funded company, having raised a total of $14.13M across 4 funding rounds to date.
Massive Bio was founded in 2014 and is headquartered in New York, United States. Operations center on the healthcare technology sector, where AI-driven platforms are utilized for clinical trial management. Services encompass real-time patient identification, trial matching, ongoing monitoring, and coordination assistance. Full-stack engineering solutions are employed to support efficient trial processes across various locations.
Massive Bio has 5 investors. Key investors include ImpactAssets, Revo Capital, Kenan Turnacioglu, DEG, and 500 Istanbul.
The website of Massive Bio receives about 155 thousand visits a month and ranks #353,083 among all websites worldwide.